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Summary
The cytoplasmic Elmo1:Dock180 complex acts as a guanine
nucleotide exchange factor (GEF) for the small GTPase
Rac and functions downstream of the phagocytic receptor
BAI1 during apoptotic cell clearance, and in the entry of
Salmonella and Shigella into cells [1–7]. We discovered an
unexpected binding between Elmo1 and the Mediator
complex subunit Med31. The Mediator complex is a regula-
tory hub for nearly all gene transcription via RNA poly-
merase II, bridging the general transcription machinery
with gene-specific regulatory proteins [8–14]. Med31 is the
smallest and the most evolutionarily conserved Mediator
subunit [15, 16], and knockout of Med31 results in embryonic
lethality in mice [17]; however, Med31 function in specific
biological contexts is poorly understood. We observed that
in primary macrophages, during Salmonella infection,
Elmo1 and Med31 specifically affected expression of the
cytokine genes Il10 and Il33 among the >25 genesmonitored.
Although endogenous Med31 is predominantly nuclear
localized, Elmo1 increased the cytoplasmic localization of
Med31. We identify ubiquitination as a novel posttransla-
tional modification of Med31, with the cytoplasmicmonoubi-
quitinated form of Med31 being enhanced by Elmo1. These
data identify Elmo1 as a novel regulator of Med31, revealing
a previously unrecognized link between cytoplasmic sig-
naling proteins and the Mediator complex.Results and Discussion
Elmo1 Binds the Mediator Complex Subunit Med31
In a yeast two-hybrid screen in which full-length murine Elmo1
(amino acids 1–727) (Figure 1A) was used as bait, we unex-
pectedly identified Med31 as a binding partner from a 7-day
mouse embryo library (Figure 1B). The Elmo1:Med31 interac-
tion was confirmed in mammalian cells, whereMed31 copreci-
pitated full-length Elmo1 from lysates (Figure 1C) under a
variety of salt and detergent concentrations (see Figure S1A
available online), suggesting a stable interaction. Elmo1
binding to Med31 also occurred at endogenous levels of6Present address: Department of Life Science, Gwangju Institute of Science
and Technology, Gwangju 500-712, South Korea
*Correspondence: ravi@virginia.eduMed31 (Figure S1B). Further mapping of the interaction in
the yeast two-hybrid system and in mammalian cells
revealed that Med31 interacts with the C-terminal portion
(amino acids 532–727) of Elmo1, but not the N-terminal regions
(Figures 1B and 1C). Deletion of the C-terminal 20 amino
acids of Elmo1 (1–707), which contains a PxxP motif, failed
to bind Med31 (Figure 1C). Proline-to-alanine mutations
within the PxxP motif of full-length Elmo1 (Elmo1 AxxA) abro-
gated the Elmo1-Med31 binding (Figure 1D), suggesting a
critical role for this PxxP motif. These observations suggested
a novel and unexpected interaction between a predominantly
nuclear protein, Med31, and a cytoplasmic signaling protein,
Elmo1.
Elmo1 Binds the Same Region of Med31 Involved in
Binding to Med7
The structure of yeast Med31, cocrystallized with the
N-terminal region of another Mediator subunit, Med7
(Med7N), revealed that the hydroxyl groups of two evolution-
arily conserved tyrosine residues in Med31 (Y33 and Y63)
were in close proximity to proline-rich regions of Med7N
[16] (Figure S3). To test whether Med31 might use these
tyrosines to bind the PxxP motif of Elmo1, we introduced
phenylalanine substitutions (Y33F or Y63F) into murine
Med31. The Y33F mutant, but not the Y63F mutant, retained
the ability to coprecipitate Elmo1 (Figure 1E). These data
identified Y63 in Med31 and the PxxP motif within Elmo1
as key components of the interaction and suggested that
other proline-rich containing proteins can replace Med7N in
binding to Med31.
Elmo1:Med31 Interaction Is Distinct from the
Elmo1:Dock180 Complex
To date, all of the functions associated with Elmo1 in mamma-
lian and Caenorhabditis elegansmodels are mediated through
its interaction with the large protein Dock180, with the Elmo1:
Dock180 complex functioning as a bipartite GEF for the
GTPase Rac [18]. We asked whether Med31 might be part of
the Elmo1:Dock180 complex. Whereas Elmo1 could readily
associate with either Med31 or Dock180 (Figure 1F, lanes 5,
9, 11, and 15), Med31 did not bind Dock180, nor was it part
of the Elmo1:Dock180 complex (Figure 1F, lanes 6, 8, 10, 12,
14, and 16). When all three proteins were coexpressed,
Elmo1 appeared to favor Dock180 binding over Med31 (Fig-
ure 1F, lanes 8, 12, and 16). These data suggest that the
Elmo1:Med31 complex is distinct from the Elmo1:Dock180
complex.
As a corollary, we asked whether Elmo1 might associate
with the Med31:Med7 subcomplex. Whereas Med31 could
associate independently with both Elmo1 (Figure 1G, lanes 5
and 9) and Med7 (Figure 1G, lanes 6 and 14), Elmo1 was not
found in the same complex with Med7 when coexpressed
with or without Med31 (Figure 1G). Although qualitative,
when all three proteins were overexpressed, Med31 appeared
to favor binding Med7 over Elmo1 (Figure 1G, lanes 8, 12, and
16). These data suggest that the Elmo1:Med31 complex is
distinct from the Med31:Med7 complex and, by extrapolation,
the larger Mediator complex.
Figure 1. The Engulfment Protein Elmo1 Inter-
acts with the Mediator Complex Subunit Med31
(A) Schematic representation of Elmo1 protein.
C-terminal PxxP (wild-type) and AxxA (mutant)
motifs are indicated. PH, pleckstrin homology.
(B) In a yeast two-hybrid assay, Med31 interacts
with full-length Elmo1 and the C-terminal PxxP-
containing fragment of Elmo1 (532–727), but not
with a PxxP-deletion mutant of Elmo1 (1–558),
as determined by growth on selective (His2
Leu2Trp2) and nonselective (His+Leu2Trp2)
media at 10-fold serial dilutions.
(C) The C-terminal PxxP motif of Elmo1 is
required for the interactionwithMed31. The inter-
action in mammalian cells between GST-Med31
and Elmo1-FLAG or the Elmo1 fragments was
analyzed by transiently expressing the indicated
proteins in 293T cells, followed by precipitations
and immunoblotting.
(D) Mutation of the Elmo1 PxxP motif to AxxA
abolishes the interaction with Med31.
(E) Med31 residue Y63 is required for binding to
Elmo1.
(F) Med31:Elmo1 and Elmo1:Dock180 complexes
are distinct. Epitope-tagged Med31, Elmo1, and
Dock180 were transiently expressed as indi-
cated, precipitated via epitope tag, and immuno-
blotted as shown.
(G) Elmo1 is not part of the Med31:Med7
subcomplex. Indicated proteins were expressed,
and their association was determined by pre-
cipitation with the indicated tags and immuno-
blotting.
See also Figures S1 and S3.
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163Elmo1 Promotes Relocalization of Med31 from the Nucleus
to the Cytoplasm
Med31 is thought to be a predominantly nuclear protein.
Consistent with this, we observed by fluorescencemicroscopy
that endogenousMed31 was largely nuclear localized (Figures
2A–2C), though faint cytoplasmic localization was reproduc-
ibly detected. Additionally, overexpressed Med31 was also
primarily nuclear localized (Figures 2J–2L). Surprisingly, ex-
pression of Elmo1 in cells resulted in increased cytoplasmic
localization of endogenous Med31 (Figures 2D–2F) in 85% of
Elmo1-expressing cells. In contrast, expression of the Elmo1
AxxA mutant, which does not bind Med31, did not affect the
subcellular localization of endogenous Med31 (Figures 2G–
2I). Elmo1 also resulted in increased cytoplasmic localization
of overexpressed Med31 (Figures 2M–2O). The C-terminal
portion of Elmo1 (532–727), which is sufficient to bind
Med31, also resulted in cytoplasmic translocation of Med31
(Figures 2P–2R). Med31 remained largely nuclear whencoexpressed with mutants of Elmo1
unable to bind Med31, either the PxxP
deletion mutant (Figures 2S–2U) or the
Elmo1 AxxA mutant (Figures 2V–2X).
Biochemical fractionation studies
also revealed that Elmo1 was largely
cytoplasmic, with minimal detection in
nuclear extracts (Figure 2Y, lanes 6, 8,
10, and 12). However, Med31 was
detectable in both nuclear and cyto-
plasmic fractions (Figure 2Y, lanes 7, 8,
11, and 12), consistent with the immuno-
fluorescence imaging (Figures 2J–2O).The level of Med31 in the cytoplasmic fraction increased
in the presence of Elmo1. These data suggest that the
Elmo1:Med31 interaction occurs predominantly in the cyto-
plasm. To our knowledge, this is the first demonstration of
a cytoplasmic binding partner of Med31.
Mice and humans express three Elmo homologs, Elmo1,
Elmo2, and Elmo3. Elmo1 is ubiquitously expressed, with en-
riched expression in cells of the monocyte/macrophage
lineage, whereas Elmo2 and Elmo3 have more restricted ex-
pression patterns [1]. Elmo1 and Elmo2 readily associated
with Med31, whereas Elmo3 did not bind Med31 (Figure S2A).
Consistent with this result, coexpression of Med31 with Elmo1
or Elmo2 resulted in increased cytoplasmic localization of
Med31 (Figures S2E–S2J), whereas coexpression with Elmo3
did not (Figures S2K–S2M). Collectively, these data reveal
that Elmo1 and Elmo2 proteins promote the cytoplasmic
localization of Med31, dependent upon the C-terminal PxxP
motif-mediated binding to Med31.
Figure 2. Elmo1 Interacts with Med31 in the Cytoplasm
(A–C) Endogenous Med31 in NIH 3T3 cells is primarily nuclear localized,
although cytoplasmic localization is also noticed.
(D–I) Expression of Elmo1-GFP resulted in increased levels of cytoplasmic
Med31 in 85% of transfected cells (D–F) compared to only 15% of cells ex-
pressing Elmo1 AxxA-GFP (G–I). Transfected cells with (arrow) and without
(arrowhead) increased cytoplasmic localization of endogenous Med31 are
shown.
(J–X) Med31 shows increased cytoplasmic localization when coexpressed
with Elmo1 proteins or fragments that interact with Med31. Cells expressing
GST-Med31with GFP-tagged versions of the indicated Elmo1 proteins were
visualized by immunofluorescence.
(Y) Immunoblotting of whole-cell lysates, cytoplasmic extracts, and nuclear
extracts from 293T cells expressing GST-Med31, Elmo1-FLAG, or both.
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Expression of Il33 and Il10 during Salmonella Infection
Previously, in a Drosophila cell culture model, dMed31 was
shown to be required for expression of lipopolysaccharide
(LPS)- and heat shock-activated endogenous genes but
dispensable for transcription of synthetic promoters [19].
Recent studies have also revealed that BAI1, the membrane
receptor upstream of Elmo1, can engage the LPS of Gram-
negative bacteria [6], and that the BAI1:Elmo1 module can
mediate uptake of these bacteria into macrophages. There-
fore, we asked whether murine Med31 and Elmo1 play a role
in LPS-activated gene expression in primary bone marrow-
derived macrophages (BMDMs). We performed small inter-
fering RNA (siRNA)-mediated knockdown of Elmo1, Med31,
or both Elmo1 and Med31 in the BMDMs. Forty-eight hours
after siRNA transfection, Elmo1 transcript levels were reduced
by w85%, and Med31 transcript levels were reduced by
w60% (Figure 3A). siRNA knockdown of Elmo1 did not result
in the compensatory upregulation of Elmo2 (Table S1A)
observed in BMDMs isolated from Elmo1-deficient mice [20],
nor were Elmo3 transcript levels affected (Table S1A). The
siRNA-transfected BMDMs were then infected with the
Gram-negative enteric pathogen Salmonella enterica serovar
Typhimurium (with a DinvG bacterial strain that depends on
Bai1-Elmo1-dependent cellular entry). After 6 hr, we profiled
the BMDMs for 25 different gene transcripts, including genes
encoding for cytokines, transcription factors, and cell-cycle
regulators via quantitative RT-PCR (qRT-PCR) (Table S1B).
We categorized the genes into three groups based on change
in expression after Salmonella infection: genes whose expres-
sion was upregulated >2-fold from uninfected BMDMs, those
whose expression was lowered >2-fold from uninfected
BMDMs, and those that had no change in expression after
infection.
Among the 12 genes upregulated during Salmonella infec-
tion (Table S1B), two genes encoding cytokines interleukin
33 (IL-33) and interleukin 10 (IL-10) were particularly sensitive
to loss of Elmo1 and Med31. Basally, Il33 transcript levels
were not detectable in uninfected BMDMs, but Il33 expression
was increased following Salmonella infection (Figure 3B).
Knockdown of Med31 reduced the upregulation of Il33
by >50%; similarly, knockdown of Elmo1 also decreased Il33
expression >50% after Salmonella infection (Figure 3B).
BMDMs express low levels of Il10 transcripts in the uninfected
state, but infection results in a >15-fold increase in Il10 expres-
sion (Figure 3B). Knockdown of either Med31 or Elmo1 in-
hibited the upregulation of Il10 (Figure 3B). Interestingly,
concurrent knockdown of both Med31 and Elmo1 did not
further decrease the transcript levels of Il33 or Il10 (Figure 3B).
One likely explanation is that Elmo1 andMed31 might function
in the same pathway downstream of Salmonella infection. This
requirement of Elmo1 and Med31 for upregulation of Il33 and
Il10 cytokine genes after Salmonella infection appeared
specific, because their knockdown did not affect upregulation
of the gene encoding tumor necrosis factor (Tnf) (Figure 3C).
Importantly, knockdown of Elmo1 andMed31 did not affect
the basal transcript level of any of the genes analyzed; simi-
larly, the transcript levels of genes that were downregulatedGAPDH was used as a cytoplasmic marker, p53 as a nuclear marker,
and b-actin as a loading control.
Scale bars in (A) and (J) represent 10 mm and apply to (A)–(X). See also
Figure S2.
Figure 3. siRNA Knockdown of Med31 and
Elmo1 Decreases Transcription of Specific
Genes in Bone Marrow-Derived Macrophages
after Salmonella Infection
(A) qRT-PCR analysis of knockdown efficiency in
bone marrow-derived macrophages (BMDMs)
transfected with siRNA targeting Elmo1 (E1)
and/or Med31 (M31). Total siRNA transfected in
each sample was kept constant by addition of
control (Ctrl) siRNA.
(B) Analysis of Il33 and Il10 transcript levels from
siRNA-transfected BMDMs, either 6 hr post
Salmonella (DinvG) infection (gray bars) or unin-
fected (white bars), demonstrating a statistically
significant decrease in transcript levels with
knockdown of Elmo1 or Med31.
(C) siRNA knockdown of Elmo1 or Med31 in
BMDM cells in response to Salmonella (DinvG)
infection does not affect other transcripts with
three examples shown here: a gene that was up-
regulated postinfection (Tnf), one transcript
unchanged with infection (Tgfb1), and one tran-
script downregulated after infection (Nfatc1). All
transcript levels were normalized to the reference
gene Hprt1.
Data are presented as mean6 SD. Data for other
transcripts analyzed are shown in Table S1B.
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Salmonella infection (Table S1B) were also unaffected by
loss of Elmo1 orMed31. All cytokine genesmeasuredwere up-
regulated following infection, with the exception of the gene
encoding transforming growth factor b1 (Tgfb1), whose
expression was unchanged (Figure 3C). Three of the four
genes that were downregulated after infection encode tran-
scription factors, including the nuclear factor of activated
T cells (NFAT)c1 gene (Nfatc1) (Figure 3C). Knockdown of
Elmo1, Med31, or both had no effect on Tgfb1 or Nfatc1
gene expression, suggesting that siRNA knockdown of
Elmo1 and Med31 does not impact transcription globally.
Interestingly, all three genes unaffected by the siRNA knock-
down of Elmo1 and Med31 (Tnf, Tgfb1, and Nfatc1) have
high levels of basal expression in the uninfected state;
because RNA polymerase II-dependent transcription requires
the Mediator complex, these data suggest Med31 is dispens-
able for expression of some genes and that separate regula-
tory mechanisms likely exist for basal and activated gene
transcription.
Elmo1 Promotes the Ubiquitination of Med31
Elmo1 binding has been linked to modification of the ubiquiti-
nation state of Dock180, wherein coexpression of Elmo1with Dock180 decrease the poly-
ubiquitination state of Dock180 and in
turn improve the stability/half-life of
Dock180 [21]. We asked whether the
Med31 ubiquitination status might be
influenced by Elmo1. Surprisingly, the
overall ubiquitination status of Med31
was increased when coexpressed with
Elmo1 (Figure 4A). Based on the pre-
dicted molecular weight of proteins
migrating on SDS-PAGE, we observed
two prominent bands that corre-
sponded to mono- and diubiquitinatedMed31 [Med31-Ub and Med31-(Ub)2, respectively], in addition
to higher polyubiquitinated forms (Figure 4A). Whereas poly-
ubiquitination (more than four ubiquitin moieties) is often
linked to proteasomal degradation of the ubiquitin-modified
protein [22], mono- and diubiquitination have been linked to
signaling (e.g., in gene transcription via NF-kB) [23–25].
Whereas increased levels of diubiquitinated Med31-(Ub)2
were observed with coexpression of both Elmo1 and Elmo1
AxxA (Figure 4A), monoubiquitinated Med31 was present at
higher levels when coexpressed with wild-type Elmo1. As
further support that Elmo1:Med31 binding regulates Med31
ubiquitination status, the Elmo1 AxxA mutant did not
increase the monoubiquitinated form (Figure 4A). When we
examined the subcellular localization of ubiquitinated
forms of Med31, Med31-Ub was found primarily in the cyto-
plasm (Figure 4B), whereas Med31-(Ub)2 was readily detect-
able in both cytoplasmic and nuclear fractions (Figure 4B).
Coexpression with either full-length or the C-terminal portion
of Elmo1 resulted in increased cytoplasmic Med31-Ub,
whereas an N-terminal mutant of Elmo1 that lacks the
PxxP motif did not (Figure 4B). Collectively, these results
reveal that Elmo proteins that interact with Med31 can pro-
mote the monoubiquitination of Med31 in the cytoplasmic
fractions.
Figure 4. Elmo1 Promotes the Ubiquitination of
Med31
(A) Elmo1 promotes the mono- and diubiquitina-
tion of Med31. Immunoblotting of GST precipi-
tates from cell lysates expressing HA-ubiquitin,
GST-Med31, and Elmo1-GFP (wild-type, PxxP),
or Elmo1 AxxA-GFP (mutant) is shown. Molecular
weight makers are indicated.
(B) Wild-type Elmo1 promotes the cytoplasmic
monoubiquitination of Med31. Immunoblotting
of GST precipitations from cytoplasmic and
nuclear extracts of cells expressing HA-ubiquitin,
GST-Med31, Elmo1-FLAG, or Elmo1 truncation
mutants 1–558 and 532–727 is shown. Monou-
biquitinated Med31-Ub was primarily found
within the cytoplasmic extract, whereas
Med31-(Ub)2 was observed within both cyto-
plasmic and nuclear extracts. Coexpression of
Med31 with either the full-length (1–727) or
PxxP-containing fragment (532–727) of Elmo1
enhanced the levels of both cytoplasmic
Med31-Ub and nuclear Med31-(Ub)2 compared
to coexpression with a PxxP-deletion mutant of
Elmo1 (1–558).
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theMed31 protein sequences from yeast to human (Figure S3),
mutated the two conserved lysine residues within the central
consensus sequence to arginine residues (K44R and K53R),
and tested whether they would inhibit ubiquitination of
Med31. Unfortunately, mutation of these two conserved lysine
residues did not disrupt the ubiquitination of Med31 (data not
shown), suggesting that ubiquitinationmay occur at a noncon-
served lysine residue in murine Med31, or that perhaps
compensatory ubiquitination may occur at more than one
site on Med31.
Collectively, the data presented in this report provide
several interesting observations. First, this work identifies
cytoplasmic Elmo1 as a previously unrecognized partner of
the Med31 subunit of the Mediator complex. Second, Elmo1
alters the cytoplasmic versus nuclear distribution of Med31.
Third, we identify a previously unknown posttranslational
modification of Med31, and the monoubiquitinated form is
modified by Elmo1. Fourth, in a physiological context where
Elmo1 has previously been shown to play a role, Med31 and
Elmo1 are required for the activated expression of the same
subset of genes in primary macrophages; in particular, during
the response of immune cells to Salmonella infection, both
Elmo1 andMed31 influence the same set of genes, suggesting
a possible conserved role for Med31 in LPS-activated gene
expression. Interestingly, among the >25 genes analyzed,
Elmo1 and Med31 were required for transcription of the cyto-
kine genes Il33 and Il10, suggesting a specificity in the expres-
sion of genes controlled by these two molecules.
The Mediator complex has been reported to include over 30
subunits, and many subunits are believed to influence a
distinct subset of genes through their myriad protein-protein
interactions with non-Mediator complex proteins [11, 14], but
the role of cytoplasmic proteins in regulating specificMediator
subunits has been unclear. Given the striking cytoplasmic re-
localization ofMed31when coexpressedwith Elmo1, our initial
hypothesis was that Elmo1 might affect Med31-dependent
gene transcription by sequestering Med31 in the cytoplasm.
Our siRNA studies in macrophages are inconsistent witha simple sequestrationmodel. Although ourmutational studies
were unsuccessful in identifying the specific lysine residues
ubiquitinated on Med31, future studies targeting multiple
lysines might provide insights on how ubiquitination may
influence Med31 interactions with other components of the
Mediator complex. Given that Elmo1 and Med31 (as well as
the Mediator complex) are highly evolutionarily conserved,
this work suggests new considerations on the regulation of
specific genes during biological processes, including path-
ogen-induced gene transcription.
Experimental Procedures
Preparation of Bone Marrow-Derived Macrophages and Salmonella
Infection
All mouse experiments were performed according to protocols approved by
the Animal Care and Use Committee of the University of Virginia. Bone
marrow-derived macrophages were generated from C57BL/6 donor mice
as described previously [26] and were maintained in differentiation medium
consisting of Dulbecco’s modified Eagle’s medium with 10% fetal bovine
serum, 10% L929-conditioned media, and antibiotics. Using an Amaxa
mouse macrophage nucleofector kit (Lonza), BMDMs were transfected
with a siGENOME SMARTpool containing four siRNAs targeting mouse
Elmo1 (M-041254-00, Dharmacon) and/or Med31 (M-047061-01) and then
incubated for 48 hr to recover; total siRNA was kept constant with siGE-
NOME nontargeting siRNA pool #2 (D-001206-14). siRNA-transfected
BMDMswere plated at 1.03 105 cells per well in 96-well plates and infected
with Salmonella enterica serovar Typhimurium (DinvG) as described previ-
ously [6]. BMDM mRNA was isolated 6 hr postinfection using an RNeasy
kit (QIAGEN). cDNA was generated from isolated mRNA using random
primers and a SuperScript III First-Strand Synthesis kit (Life Technologies).
Transcript levels were measured by qRT-PCR using TaqMan gene expres-
sion assays (see Supplemental Experimental Procedures) and a One-Step
Plus RT-PCR instrument (Life Technologies). Results were normalized to
transcripts of the reference gene Hprt1.
Please see Supplemental Experimental Procedures for detailed materials
and methods.
Supplemental Information
Supplemental Information includes three figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online
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